查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1468205

2024-2032 年按行業、類型、包裝和地區分類的藥品合約包裝市場報告

Pharmaceutical Contract Packaging Market Report by Industry, Type, Packaging, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球藥品合約包裝市場規模達到217億美元。日益成長的外包趨勢、對藥物和醫療設備的需求不斷成長、嚴格的監管合規性、產品多樣化和成本效益、重大技術進步以及日益成長的環境考慮是推動市場的一些主要因素。

藥品合約包裝是指製藥公司將包裝服務外包給專業的合約包裝公司。這些公司配備了必要的基礎設施和專業知識來處理醫藥產品的包裝，包括藥品、醫療器材和相關醫療保健物品。藥品合約包裝的過程涉及各個階段，包括設計、標籤和最終產品包裝的組裝。合約包裝公司確保遵守監管指南和行業標準，例如良好生產規範 (GMP) 和品質保證 (QA) 協議。透過選擇合約包裝服務，製藥公司可以受益於多種優勢。它使他們能夠專注於自己的核心能力，例如研發，同時將包裝責任委託給專家。這提高了營運效率並縮短了產品的上市時間。此外，合約包裝公司可以透過利用規模經濟和最佳化包裝流程來提供具有成本效益的解決方案。

製藥公司擴大將其非核心活動（包括包裝）外包給合約包裝公司。這使他們能夠專注於研發等核心能力，同時受益於合約包裝專家的專業知識和效率。此外，製藥業也受到世界各地衛生當局實施的嚴格法規和品質標準的約束。合約包裝公司熟悉這些法規，確保藥品的包裝和標籤符合良好生產規範 (GMP) 和其他相關準則。除此之外，隨著新藥開發、個人化藥物和創新醫療設備的發展，醫藥市場也不斷擴大。合約包裝公司提供客製化且靈活的解決方案，以滿足這些產品的不同包裝要求。除此之外，合約包裝無需對包裝基礎設施和設備進行大量投資，從而為製藥公司提供成本優勢。相反，他們可以利用成熟的合約包裝提供者的能力，從而節省成本。與此一致的是，全球製藥業正在經歷顯著成長，特別是在新興市場。隨著製藥公司將業務範圍擴大到新的地區，他們尋求可靠的合約包裝合作夥伴，以確保在不同市場中提供高效且合規的包裝。此外，合約包裝公司不斷在其流程中採用先進技術和自動化。這些創新提高了包裝效率，減少了錯誤，並提高了整體生產力，使其成為製藥公司有吸引力的合作夥伴。此外，人們對永續發展和環境影響的認知不斷增強，對環保和可回收包裝解決方案的需求不斷成長。合約包裝公司正在根據這些綠色舉措調整其產品，以滿足市場需求。

藥品合約包裝市場趨勢/促進因素：

日益成長的外包趨勢

製藥公司擴大轉向合約包裝公司來滿足其包裝需求。這種轉變主要是由於希望專注於核心競爭力（例如藥物開發和行銷），同時將包裝的專門任務委託給經驗豐富的專業人員。透過外包包裝，製藥公司可以簡化營運、降低營運成本並提高整體效率。合約包裝公司提供包裝材料、設計和法規遵循方面的專業知識，使製藥公司能夠及時向市場提供高品質的產品。此外，外包提供了適應產品需求波動的靈活性，使製藥公司能夠迅速應對不斷變化的市場動態。

嚴格的監理合規性

製藥業受到世界各地衛生當局的嚴格監管，以確保病患安全和產品功效。對於製藥公司來說，遵守良好生產規範 (GMP) 和其他監管指南至關重要。合約包裝公司專門遵守這些嚴格的法規，因為他們對適用的品質標準和行業最佳實踐有深入的了解。他們的專業知識確保藥品在整個供應鏈中得到準確的標籤、包裝和可追溯，從而降低不合規和潛在法律問題的風險。透過與合約包裝供應商合作，製藥公司可以維持其生產安全可靠產品的聲譽，同時減輕與監管不合規相關的風險。

藥品和醫療器材的需求不斷成長

全球醫藥市場不斷擴大，不同地區對藥品和醫療器材的需求不斷增加。當製藥公司尋求打入新市場時，他們會遇到獨特的包裝要求和地區法規。合約包裝公司提供在地化的專業知識和能力，使製藥公司能夠無縫應對不同市場的複雜性。這些公司可以調整包裝設計、標籤和語言翻譯，以符合當地法規和文化偏好。透過與合約包裝供應商合作，製藥公司可以有效地進入新市場、利用成長機會並覆蓋更廣泛的客戶群。這種市場擴張策略使製藥公司能夠擴大其市場佔有率，同時最大限度地減少物流挑戰並確保一致且合規的包裝方法。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球藥品合約包裝產業

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 價格分析
    • 主要價格指標
    • 價格結構
    • 價格趨勢
  • 市場區隔：依行業
  • 市場區隔：按類型
  • 市場區隔：按包裝
  • 市場區隔：按地區
  • 市場預測
  • SWOT分析
    • 概述
    • 優勢
    • 弱點
    • 機會
    • 威脅
  • 價值鏈分析
    • 原物料採購
    • 製造業
    • 行銷
    • 分配
    • 出口
    • 最終用途
  • 波特五力分析
    • 概述
    • 買家的議價能力
    • 供應商的議價能力
    • 競爭程度
    • 新進入者的威脅
    • 替代品的威脅
  • 非專利藥產業的法規
  • 主要市場促進因素與成功因素

第 6 章：市場區隔：依行業

  • 小分子
    • 市場走向
    • 市場預測
  • 生物製藥
    • 市場走向
    • 市場預測
  • 疫苗
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按類型

  • 無菌
    • 市場走向
    • 市場預測
  • 非無菌
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依包裝

  • 塑膠瓶
    • 市場走向
    • 市場預測
  • 瓶蓋和瓶蓋
    • 市場走向
    • 市場預測
  • 吸塑包裝
    • 市場走向
    • 市場預測
  • 預充式注射器
    • 市場走向
    • 市場預測
  • 注射用小瓶和安瓿
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 美國
    • 市場走向
    • 市場預測
  • 歐洲
    • 市場走向
    • 市場預測
  • 中國
    • 市場走向
    • 市場預測
  • 印度
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 10 章：競爭格局

  • 市場結構
  • 關鍵參與者

第 11 章：藥品合約包裝流程

  • 產品概述
  • 詳細流程
  • 涉及的各種類型的單元操作
  • 質量平衡和原料要求

第 12 章：專案細節、要求與涉及的成本

  • 土地需求和支出
  • 建設需求及支出
  • 工廠佈局
  • 工廠機械
  • 原料需求及支出
  • 交通需求及支出
  • 公用事業要求和支出
  • 人手需求及開支
  • 其他資本投資

第 13 章：貸款與財務援助

第 14 章：專案經濟學

  • 專案資本成本
  • 技術經濟參數
  • 供應鏈各層面的產品定價與利潤
  • 稅金和折舊
  • 收入預測
  • 支出預測
  • 財務分析
  • 利潤分析

第 15 章：關鍵球員簡介

Product Code: SR112024A524

The global pharmaceutical contract packaging market size reached US$ 21.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 39.9 Billion by 2032, exhibiting a growth rate (CAGR) of 6.8% during 2024-2032. The increasing outsourcing trends, rising demand for medications and medical devices, stringent regulatory compliance, product diversification and cost-effectiveness, significant technological advancements, and increasing environmental considerations are some of the major factors propelling the market.

Pharmaceutical contract packaging refers to the outsourcing of packaging services by pharmaceutical companies to specialized contract packaging firms. These firms are equipped with the necessary infrastructure and expertise to handle the packaging of pharmaceutical products, including medications, medical devices, and related healthcare items. The process of pharmaceutical contract packaging involves various stages, including design, labeling, and assembly of the final product packaging. The contract packaging companies ensure compliance with regulatory guidelines and industry standards, such as Good Manufacturing Practices (GMP) and Quality Assurance (QA) protocols. By opting for contract packaging services, pharmaceutical companies can benefit from several advantages. It allows them to focus on their core competencies, such as research and development, while entrusting packaging responsibilities to experts. This leads to increased operational efficiency and reduced time-to-market for their products. Additionally, contract packaging firms can offer cost-effective solutions by leveraging economies of scale and optimizing packaging processes.

Pharmaceutical companies are increasingly outsourcing their non-core activities, including packaging, to contract packaging firms. This allows them to focus on core competencies like research and development, while benefiting from the expertise and efficiency of contract packaging specialists. Additionally, the pharmaceutical industry is subject to strict regulations and quality standards imposed by health authorities worldwide. Contract packaging companies are well-versed in these regulations, ensuring that pharmaceutical products are packaged and labeled in compliance with Good Manufacturing Practices (GMP) and other relevant guidelines. Other than this, the pharmaceutical market is continuously expanding with new drug developments, personalized medicines, and innovative medical devices. Contract packaging firms offer customized and flexible solutions to accommodate the diverse packaging requirements of these products. Besides this, contract packaging offers cost advantages to pharmaceutical companies by eliminating the need for heavy investments in packaging infrastructure and equipment. Instead, they can leverage the capabilities of established contract packaging providers, resulting in cost savings. In line with this, the global pharmaceutical industry is witnessing significant growth, especially in emerging markets. As pharmaceutical companies expand their reach to new regions, they seek reliable contract packaging partners to ensure efficient and compliant packaging in diverse markets. Furthermore, contract packaging companies are continually adopting advanced technologies and automation in their processes. These innovations improve packaging efficiency, reduce errors, and enhance overall productivity, making them attractive partners for pharmaceutical firms. Moreover, increasing awareness about sustainability and environmental impact has led to a growing demand for eco-friendly and recyclable packaging solutions. Contract packaging companies are aligning their offerings with these green initiatives to meet market demands.

Pharmaceutical Contract Packaging Market Trends/Drivers:

Increasing Outsourcing Trend

Pharmaceutical companies are increasingly turning to contract packaging firms to handle their packaging needs. This shift is primarily driven by the desire to focus on core competencies, such as drug development and marketing, while entrusting the specialized task of packaging to experienced professionals. By outsourcing packaging, pharmaceutical companies can streamline their operations, reduce operational costs, and improve overall efficiency. Contract packaging firms offer expertise in packaging materials, design, and regulatory compliance, which allows pharmaceutical companies to deliver high-quality products to the market in a timely manner. Additionally, outsourcing provides the flexibility to adapt to fluctuations in product demand, allowing pharmaceutical companies to respond swiftly to changing market dynamics.

Stringent Regulatory Compliance

The pharmaceutical industry is heavily regulated by various health authorities worldwide to ensure patient safety and product efficacy. Compliance with Good Manufacturing Practices (GMP) and other regulatory guidelines is paramount for pharmaceutical companies. Contract packaging firms specialize in adhering to these strict regulations, as they possess in-depth knowledge of the applicable quality standards and industry best practices. Their expertise ensures that pharmaceutical products are accurately labeled, packaged, and traceable throughout the supply chain, reducing the risk of non-compliance and potential legal issues. By partnering with contract packaging providers, pharmaceutical companies can maintain their reputation for producing safe and reliable products, while mitigating the risks associated with regulatory non-compliance.

Rising Demand for Medications and Medical Devices

The global pharmaceutical market is continuously expanding, with increasing demand for medications and medical devices across diverse regions. As pharmaceutical companies seek to penetrate new markets, they encounter unique packaging requirements and regional regulations. Contract packaging firms offer localized expertise and capabilities, enabling pharmaceutical companies to navigate the complexities of different markets seamlessly. These firms can adapt packaging designs, labeling, and language translations to comply with local regulations and cultural preferences. By partnering with contract packaging providers, pharmaceutical companies can efficiently enter new markets, capitalize on growth opportunities, and reach a broader customer base. This market expansion strategy allows pharmaceutical companies to extend their market presence while minimizing logistical challenges and ensuring a consistent and compliant packaging approach.

Pharmaceutical Contract Packaging Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global pharmaceutical contract packaging market report, along with forecasts at the global and regional levels for 2024-2032. Our report has categorized the market based on industry, type and packaging.

Breakup by Industry:

Small Molecule

Biopharmaceutical

Vaccine

The report has provided a detailed breakup and analysis of the market based on the industry. This includes small molecule, biopharmaceutical, and vaccine.

The small molecule pharmaceutical industry encompasses a broad range of traditional drugs that consist of low molecular weight compounds. These drugs are typically synthesized through chemical processes, and they constitute a significant portion of the pharmaceutical market. Small molecule drugs are widely used to treat various medical conditions and diseases, including cardiovascular disorders, infectious diseases, and metabolic disorders. Due to their relatively simple structure, small molecules can be easily mass-produced and formulated into different dosage forms, such as tablets and capsules. They also have a well-established manufacturing and packaging process, making them cost-effective to produce and distribute. The small molecule pharmaceutical industry remains a vital segment of the overall pharmaceutical market and continues to experience steady growth due to the constant demand for therapeutics targeting prevalent medical conditions.

The biopharmaceutical industry focuses on the development and production of pharmaceutical products derived from biological sources, such as living organisms or their components. Biopharmaceuticals include a wide range of products like monoclonal antibodies, vaccines, recombinant proteins, and gene therapies. These products are often more complex in structure and require advanced manufacturing processes, including biotechnology techniques like cell culture and genetic engineering. The biopharmaceutical sector has witnessed significant growth in recent years due to the increasing prevalence of chronic diseases, personalized medicine approaches, and advancements in biotechnology research. Biopharmaceutical products offer targeted and precise treatments, which have revolutionized disease management and patient care. As a result, this industry has become a key driver of innovation and growth within the pharmaceutical market.

The vaccine industry is dedicated to the development, manufacturing, and distribution of vaccines that prevent infectious diseases and protect public health. Vaccines are biological products designed to stimulate an immune response, providing immunity against specific pathogens. They play a crucial role in preventing the spread of communicable diseases and reducing the burden of infectious outbreaks. The vaccine industry has experienced remarkable growth and technological advancements, particularly in response to global health challenges like the COVID-19 pandemic. Vaccine development requires rigorous testing, clinical trials, and adherence to stringent regulatory standards to ensure safety and efficacy. The ongoing research in immunology and molecular biology continues to drive the innovation of novel vaccines to combat emerging diseases and improve public health outcomes globally. As governments and healthcare organizations prioritize vaccination programs, the vaccine industry remains a vital and indispensable component of the pharmaceutical market.

Breakup by Type:

Sterile

Non-Sterile

Sterile pharmaceutical contract packaging holds the largest share in the market

A detailed breakup and analysis of the market based on the type has also been provided in the report. This includes sterile and non-sterile. According to the report, sterile packaging accounted for the largest market share.

Sterile products are those that are free from any viable microorganisms, making them suitable for direct administration into the body, such as through injections or infusions. They are essential in various medical settings, including hospitals, clinics, and home healthcare. The sterile products are widely used in treating serious and life-threatening medical conditions that require immediate and precise intervention. These products are crucial in emergency situations and surgical procedures, where contamination can have severe consequences. Additionally, the stringent regulatory requirements surrounding the manufacturing and distribution of sterile products contribute to their significance. Health authorities have strict guidelines to ensure the quality and sterility of these products, making the manufacturing process complex and specialized. Moreover, the growing demand for biopharmaceuticals and injectable drugs has further driven the dominance of the sterile segment. As biologics and personalized medicine gain popularity, the need for sterile packaging and administration becomes more pronounced, propelling the growth of this segment within the pharmaceutical market.

Breakup by Packaging:

Plastic Bottles

Caps and Closures

Blister Packs

Prefilled Syringes

Parenteral Vials and Ampoules

Others

Plastic bottles dominate the market

The report has provided a detailed breakup and analysis of the market based on the packaging. This includes plastic bottles caps and closures, blister packs, prefilled syringes, parenteral vials and ampoules, and others. According to the report, plastic bottles represented the largest segment.

Plastic bottles offer a combination of versatility and cost-effectiveness that makes them widely preferred across various industries, including pharmaceuticals. Their lightweight nature and durability make them easy to handle during manufacturing, transportation, and storage, reducing overall logistics costs. Additionally, plastic bottles provide excellent barrier properties, protecting pharmaceutical products from external contaminants, moisture, and UV light. This safeguard helps maintain product integrity and extends shelf life, ensuring that medications and healthcare products remain effective and safe for consumption. Furthermore, plastic bottles come in a wide range of shapes and sizes, allowing for customization to meet specific packaging requirements. This flexibility makes them suitable for packaging various forms of pharmaceuticals, from liquid syrups and oral medications to solid tablets and capsules. Moreover, the recyclability of plastic bottles aligns with growing environmental concerns, as manufacturers and consumers increasingly prioritize sustainable packaging solutions. As the demand for eco-friendly packaging continues to rise, plastic bottles' recyclability contributes to their continued dominance as the largest segment in the pharmaceutical packaging market.

Breakup by Region:

United States

Europe

China

India

Others

The United States exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include the United States, Europe, China, India, and others. According to the report, the United States was the largest market for pharmaceutical contract packaging.

The U.S. pharmaceutical market is one of the largest and most developed in the world, with a high demand for innovative drugs, medical devices, and healthcare products. The extensive pharmaceutical industry in the U.S. necessitates a robust contract packaging sector to handle the diverse packaging needs of various companies. Additionally, the U.S. pharmaceutical landscape is characterized by a dynamic regulatory environment, with stringent quality and safety standards enforced by agencies such as the Food and Drug Administration (FDA). Contract packaging companies in the U.S. are well-versed in these regulations and adhere to strict compliance protocols, providing assurance to pharmaceutical companies that their products will meet the necessary requirements. Other than this, the U.S. is home to numerous pharmaceutical companies, ranging from multinational corporations to innovative start-ups. Many of these companies prefer to outsource their packaging needs to specialized contract packaging firms to focus on their core competencies and achieve greater operational efficiency. Moreover, the presence of advanced technologies and infrastructure in the U.S. contributes to the country's dominance in the pharmaceutical contract packaging market. These resources enable contract packaging companies to offer a wide array of packaging solutions, including serialization, track-and-trace systems, and customized packaging designs. Furthermore, the U.S. contract packaging industry benefits from a highly skilled and trained workforce with expertise in various aspects of pharmaceutical packaging. This proficiency ensures that contract packaging companies can deliver high-quality and reliable packaging services to their clients.

Competitive Landscape:

Leading contract packaging companies are investing heavily in advanced technologies and automation systems. These investments aim to streamline packaging processes, reduce manual errors, and improve overall operational efficiency. Automation enables faster and more precise packaging, leading to increased production capacities and shorter time-to-market for pharmaceutical products. Additionally, key players in the market are expanding their geographic presence to tap into emerging markets and cater to the growing demand for contract packaging services globally. By establishing facilities in strategic locations, they can provide localized services and offer more cost-effective solutions to pharmaceutical companies seeking to enter new regions. Other than this, environmental sustainability has become a significant concern for consumers and businesses alike. Many key players in the pharmaceutical contract packaging market are incorporating sustainable practices, such as using eco-friendly materials and optimizing packaging designs to reduce waste. These efforts align with the increasing demand for environmentally responsible packaging solutions. Furthermore, to broaden their service offerings and cater to diverse customer needs, key players often engage in collaborations and partnerships. These collaborations may involve joint ventures, technology-sharing agreements, or strategic alliances with pharmaceutical companies and other stakeholders. Such partnerships foster innovation, knowledge exchange, and access to a wider customer base.

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided.

Key Questions Answered in This Report

  • 1. What was the size of the global pharmaceutical contract packaging market in 2023?
  • 2. What is the expected growth rate of the global pharmaceutical contract packaging market during 2024-2032?
  • 3. What are the key factors driving the global pharmaceutical contract packaging market?
  • 4. What has been the impact of COVID-19 on the pharmaceutical contract packaging market?
  • 5. What is the breakup of the global pharmaceutical contract packaging market based on the type?
  • 6. What is the breakup of the global pharmaceutical contract packaging market based on the packaging?
  • 7. What are the key regions in the global pharmaceutical contract packaging market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pharmaceutical Contract Packaging Industry

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Price Analysis
    • 5.4.1 Key Price Indicators
    • 5.4.2 Price Structure
    • 5.4.3 Price Trends
  • 5.5 Market Breakup by Industry
  • 5.6 Market Breakup by Type
  • 5.7 Market Breakup by Packaging
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast
  • 5.10 SWOT Analysis
    • 5.10.1 Overview
    • 5.10.2 Strengths
    • 5.10.3 Weaknesses
    • 5.10.4 Opportunities
    • 5.10.5 Threats
  • 5.11 Value Chain Analysis
    • 5.11.1 Raw Material Procurement
    • 5.11.2 Manufacturing
    • 5.11.3 Marketing
    • 5.11.4 Distribution
    • 5.11.5 Exports
    • 5.11.6 End-Use
  • 5.12 Porter's Five Forces Analysis
    • 5.12.1 Overview
    • 5.12.2 Bargaining Power of Buyers
    • 5.12.3 Bargaining Power of Suppliers
    • 5.12.4 Degree of Competition
    • 5.12.5 Threat of New Entrants
    • 5.12.6 Threat of Substitutes
  • 5.13 Regulations in Generic Industry
  • 5.14 Key Market Drivers and Success Factors

6 Market Breakup by Industry

  • 6.1 Small Molecule
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Biopharmaceutical
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Vaccine
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Type

  • 7.1 Sterile
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Non-Sterile
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Packaging

  • 8.1 Plastic Bottles
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Caps and Closures
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Blister Packs
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Prefilled Syringes
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Parenteral Vials and Ampoules
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by Region

  • 9.1 United States
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Europe
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 China
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 India
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Competitive Landscape

  • 10.1 Market Structure
  • 10.2 Key Players

11 Pharmaceutical Contract Packaging Process

  • 11.1 Product Overview
  • 11.2 Detailed Process Flow
  • 11.3 Various Types of Unit Operations Involved
  • 11.4 Mass Balance and Raw Material Requirements

12 Project Details, Requirements and Costs Involved

  • 12.1 Land Requirements and Expenditures
  • 12.2 Construction Requirements and Expenditures
  • 12.3 Plant Layout
  • 12.4 Plant Machinery
  • 12.5 Raw Material Requirements and Expenditures
  • 12.6 Transportation Requirements and Expenditures
  • 12.7 Utility Requirements and Expenditures
  • 12.8 Manpower Requirements and Expenditures
  • 12.9 Other Capital Investments

13 Loans and Financial Assistance

14 Project Economics

  • 14.1 Capital Cost of the Project
  • 14.2 Techno-Economic Parameters
  • 14.3 Product Pricing and Margins Across Various Levels of the Supply Chain
  • 14.4 Taxation and Depreciation
  • 14.5 Income Projections
  • 14.6 Expenditure Projections
  • 14.7 Financial Analysis
  • 14.8 Profit Analysis

15 Key Player Profiles

List of Figures

  • Figure 1: Global: Pharmaceutical Contract Packaging Market: Major Drivers and Challenges
  • Figure 2: Global: Pharmaceutical Contract Packaging Market: Sales Value Trends (in Billion US$), 2018-2023
  • Figure 3: Global: Pharmaceutical Contract Packaging Market Forecast: Sales Value Trends (in Billion US$), 2024-2032
  • Figure 4: Global: Pharmaceutical Contract Packaging Market: Breakup by Industry (in %), 2023
  • Figure 5: Global: Pharmaceutical Contract Packaging Market: Breakup by Type (in %), 2023
  • Figure 6: Global: Pharmaceutical Contract Packaging Market: Breakup by Packaging (in %), 2023
  • Figure 7: Global: Pharmaceutical Contract Packaging Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Pharmaceutical Contract Packaging Industry: SWOT Analysis
  • Figure 9: Global: Pharmaceutical Contract Packaging Industry: Value Chain Analysis
  • Figure 10: Global: Pharmaceutical Contract Packaging Industry: Porter's Five Forces Analysis
  • Figure 11: United States: Pharmaceutical Contract Packaging Market (in Million US$), 2018 & 2023
  • Figure 12: United States: Pharmaceutical Contract Packaging Market Forecast (in Million US$), 2024-2032
  • Figure 13: Europe: Pharmaceutical Contract Packaging Market (in Million US$), 2018 & 2023
  • Figure 14: Europe: Pharmaceutical Contract Packaging Market Forecast (in Million US$), 2024-2032
  • Figure 15: China: Pharmaceutical Contract Packaging Market (in Million US$), 2018 & 2023
  • Figure 16: China: Pharmaceutical Contract Packaging Market Forecast (in Million US$), 2024-2032
  • Figure 17: India: Pharmaceutical Contract Packaging Market (in Million US$), 2018 & 2023
  • Figure 18: India: Pharmaceutical Contract Packaging Market Forecast (in Million US$), 2024-2032
  • Figure 19: Others: Pharmaceutical Contract Packaging Market (in Million US$), 2018 & 2023
  • Figure 20: Others: Pharmaceutical Contract Packaging Market Forecast (in Million US$), 2024-2032
  • Figure 21: Global: Pharmaceutical Contract Packaging (Small Molecule) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Pharmaceutical Contract Packaging (Small Molecule) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Pharmaceutical Contract Packaging (Biopharmaceutical) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Pharmaceutical Contract Packaging (Biopharmaceutical) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Pharmaceutical Contract Packaging (Vaccine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Pharmaceutical Contract Packaging (Vaccine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Pharmaceutical Contract Packaging (Sterile) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Pharmaceutical Contract Packaging (Sterile) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Pharmaceutical Contract Packaging (Non-Sterile) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Pharmaceutical Contract Packaging (Non-Sterile) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Pharmaceutical Contract Packaging (Plastic Bottles) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Pharmaceutical Contract Packaging (Plastic Bottles) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Pharmaceutical Contract Packaging (Caps and Closures) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Pharmaceutical Contract Packaging (Caps and Closures) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Pharmaceutical Contract Packaging (Blister Packs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Pharmaceutical Contract Packaging (Blister Packs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Pharmaceutical Contract Packaging (Prefilled Syringes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Pharmaceutical Contract Packaging (Prefilled Syringes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Pharmaceutical Contract Packaging (Parenteral Vials and Ampoules) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Pharmaceutical Contract Packaging (Parenteral Vials and Ampoules) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Pharmaceutical Contract Packaging (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Pharmaceutical Contract Packaging (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Pharmaceutical Contract Packaging: Detailed Process Flow
  • Figure 44: Pharmaceutical Contract Packaging: Conversion Rate of Feedstocks
  • Figure 45: Pharmaceutical Contract Packaging Plant: Proposed Plant Layout
  • Figure 46: Pharmaceutical Contract Packaging Plant: Breakup of Capital Costs (in %)
  • Figure 47: Pharmaceutical Contract Packaging Industry: Profit Margins at Various Levels of the Supply Chain
  • Figure 48: Pharmaceutical Contract Packaging Plant: Production Cost Breakup (in %)

List of Tables

  • Table 1: Global: Pharmaceutical Contract Packaging Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Pharmaceutical Contract Packaging Market Forecast: Breakup by Industry (in Million US$), 2024-2032
  • Table 3: Global: Pharmaceutical Contract Packaging Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 4: Global: Pharmaceutical Contract Packaging Market Forecast: Breakup by Packaging (in Million US$), 2024-2032
  • Table 5: Global: Pharmaceutical Contract Packaging Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Pharmaceutical Contract Packaging Market: Competitive Structure
  • Table 7: Global: Pharmaceutical Contract Packaging Market: Key Players
  • Table 8: Pharmaceutical Contract Packaging Plant: Costs Related to Land and Site Development (in US$)
  • Table 9: Pharmaceutical Contract Packaging Plant: Costs Related to Civil Works (in US$)
  • Table 10: Pharmaceutical Contract Packaging Plant: Costs Related to Machinery Unit (in US$)
  • Table 11: Pharmaceutical Contract Packaging Plant: Raw Material Requirements (in Tons/Day) and Expenditures (in US$/Ton)
  • Table 12: Pharmaceutical Contract Packaging Plant: Costs Related to Salaries and Wages (in US$)
  • Table 13: Pharmaceutical Contract Packaging Plant: Costs Related to Other Capital Investments (in US$)
  • Table 14: Details of Financial Assistance Offered by Financial Institutions
  • Table 15: Pharmaceutical Contract Packaging Plant: Capital Costs (in US$)
  • Table 16: Pharmaceutical Contract Packaging Plant: Techno-Economic Parameters
  • Table 17: Pharmaceutical Contract Packaging Plant: Taxation and Depreciation (in US$)
  • Table 18: Pharmaceutical Contract Packaging Plant: Income Projections (in US$)
  • Table 19: Pharmaceutical Contract Packaging Plant: Expenditure Projections (in US$)
  • Table 20: Pharmaceutical Contract Packaging Plant: Cash Flow Analysis Without Considering the Income Tax Liability (in US$)
  • Table 21: Pharmaceutical Contract Packaging Plant: Cash Flow Analysis on Considering the Income Tax Liability (in US$)
  • Table 22: Pharmaceutical Contract Packaging Plant: Profit and Loss Account (in US$)